Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

253.16 +2.24 (+0.89%)
Streaming Delayed Price Updated: 1:57 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
17 18 Next >
News headline image
(RMD) - Analyzing ResMed's Short Interest ↗
 
Via Benzinga
News headline image
ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
ResMed’s masks with magnets are safe when used in accordance with the updated Instructions for Use 
From ResMed Inc.
Via GlobeNewswire
News headline image
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today ↗
 
Via Benzinga
News headline image
ResMed Secures Significant Victory in Patent Fight Against New York University
From ResMed Inc.
Via GlobeNewswire
News headline image
Why NYSE:RMD qualifies as a good dividend investing stock. ↗
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
Via Chartmill
News headline image
Why the dividend investor may take a look at NYSE:RMD. ↗
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
News headline image
Is NYSE:RMD a Good Fit for Dividend Investing? ↗
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
News headline image
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
From ResMed Inc.
Via GlobeNewswire
News headline image
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion ↗
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump. 
Via Benzinga
News headline image
ResMed Adopts New Operating Model to Accelerate Long-term Growth
From ResMed Inc.
Via GlobeNewswire
News headline image
Expert Ratings for ResMed ↗
 
Via Benzinga
News headline image
2 Monster Stocks to Buy Without Any Hesitation ↗
Down 33% and 44%, these two stocks look too good to pass up today. 
Via The Motley Fool
News headline image
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In ↗
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)  
Via Benzinga
News headline image
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
News headline image
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
From ResMed Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For October 26, 2023 ↗
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion. 
Via Benzinga
News headline image
3 Stocks to Buy From the ‘Buy the Dip’ ETF ↗
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023 ↗
 
Via Benzinga
News headline image
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday ↗
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell... 
Via Benzinga
News headline image
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
From ResMed Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗
 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
News headline image
3 Top Growth Stock Picks Trading at a Massive Bargain ↗
These growth stock picks are trading at bargain prices and are well-positioned to rebound and deliver substantial gains in the coming months. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 283 companies set new 52-week lows. 
Via Benzinga
News headline image
Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks? ↗
The S&P 500 had a rare decline last month. 
Via The Motley Fool
Topics Stocks
News headline image
Sleep Device Player ResMed's Potential Obstacles: Analyst Weighs Obesity Drugs & Philips' Re-Entry ↗
Needham upgraded ResMed Inc (NYSE: RMD) from a Hold to Buy rating with a price target of $180 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗
 
Via Benzinga
News headline image
ResMed Announces Participation in Upcoming Conferences
From ResMed Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023 ↗
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.